International Patent: ANTI-MEGALIN ANTIBODY-DRUG CONJUGATE, FOR USE IN THE TREATMENT OF MELANOMA IN A SUBJECT, WHEREIN SAID SUBJECT HAS PREVIOUSLY BEEN TREATED WITH IFN(GAMMA) AND/OR AN IFN(GAMMA)-INDUCING COMPOUND

GENEVA, Aug. 7 -- AARHUS UNIVERSITET filed a patent application (EP2026/051914) for “ANTI-MEGALIN ANTIBODY-DRUG CONJUGATE, FOR USE IN THE TREATMENT OF MELANOMA IN A SUBJECT, WHEREIN SAID SUBJECT HAS PREVIOUSLY BEEN TREATED WITH IFN(GAMMA) AND/OR AN IFN(GAMMA)-INDUCING COMPOUND”. With publication no. WO/2026/162449, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....